Skip to main content

Usana Health Sciences Inc

USNA
Exchange
NYSE
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0000896264

No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Usana Health Sciences Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of USNA: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders169161−8
Shares10.3M10.2M−31.5K (−0.3%)
Value$646.8M$602.0M−$44.8M (−6.9%)

New holders (9)

Institutions that held Usana Health Sciences Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to USNA in Q3 2023
InstitutionSharesValue% of portfolio
West Coast Financial LLC42,121$2.47M0.37%
ExodusPoint Capital Management, LP12,037$705.0K0.01%
SG Americas Securities, LLC9,913$581.0K0.01%
HSBC Holdings PLC9,732$569.6K0.00%
Illinois Municipal Retirement Fund6,594$386.0K0.01%
Comerica Bank5,393$316.1K0.00%
Teacher Retirement System of Texas5,064$297.0K0.00%
Hillsdale Investment Management Inc.80$4.69K0.00%
Steward Financial Group LLC4$00.00%

Sold out (17)

Institutions that held Usana Health Sciences Inc at the end of Q2 2023 and filed for Q3 2023 without it.